QA: OptiNose Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001494650_2023_OptiNose_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001494650, OptiNose Inc.

  xvar xval
0 AssetsCurrent 140,484,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 795,000
3 remainder_Assets 2,943,000
4 LiabilitiesCurrent 178,730,000
5 LiabilitiesNoncurrent 626,000
6 remainder_Liabilities 21,490,000
7 CostOfGoodsAndServicesSold 9,263,000
8 SellingGeneralAndAdministrativeExpense 107,649,000
9 ResearchAndDevelopmentExpense 15,260,000
10 remainder_Expenses 16,843,000
11 remainder_Revenues 74,880,000
12 remainder_NetIncome -698,000
13 remainder_ComprehensiveNetIncome -3,000
  yvar yval
0 Assets 144,222,000
1 Liabilities 200,846,000
2 Expenses 149,015,000
3 Revenues 74,880,000
4 StockholdersEquity -56,624,000
5 NetIncome -74,833,000
6 ComprehensiveNetIncome -74,834,500
7 BaseVar 284,832,000
8 EconomicCapitalRatio -0.998

Edgar->Model Mapping

Feature Distribution

Change over Time